Simba Gill
Chief Executive Officer, Evelo Biosciences, Inc.
Companies
- Serina Therapeutics, Inc.Board member Apr 17, 2024 to now1
- Foghorn Therapeutics Inc.Board member Oct 22, 2020 to now2
- Evelo Biosciences, Inc.Board member May 8, 2018 to Nov 8, 20233
- Evelo Biosciences, Inc.Chief executive officer May 8, 2018 to Nov 8, 20233
- Evelo Biosciences, Inc.President May 8, 2018 to Nov 8, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Foghorn Therapeutics Inc. FHTX34,061 shares4$63.0K at $1.85Sep 13, 2022
- Evelo Biosciences, Inc.17,758 shares5Nov 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 8, 2023Sold 172 shares at $0.33 of Evelo Biosciences, Inc.5
- Nov 7, 2023Exercised options 1,172 shares of Evelo Biosciences, Inc.5
- Sep 28, 2023Sold 1,996 shares at $3.94 of Evelo Biosciences, Inc.6
- Sep 27, 2023Exercised options 15,000 shares of Evelo Biosciences, Inc.6
- Aug 8, 2023Sold 342 shares at $9.51 of Evelo Biosciences, Inc.7
- Aug 7, 2023Exercised options 1,171 shares of Evelo Biosciences, Inc.7
- May 8, 2023Sold 3,537 shares at $0.13 of Evelo Biosciences, Inc.8
- May 7, 2023Exercised options 23,437 shares of Evelo Biosciences, Inc.9
- Sep 13, 2022Gift 47,939 shares of Foghorn Therapeutics Inc.4
- Sep 12, 2022Exercised options 82,000 shares at $0.73 of Foghorn Therapeutics Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Sep 29, 2023
- 7SEC EDGARForm 4 filed Aug 9, 2023
- 8SEC EDGARForm 4 filed May 10, 2023
- 9SEC EDGARForm 4 filed May 9, 2023